
Hira Pharmaceutical Industries Private Limited
About Hira Pharmaceutical Industries Private Limited
Data last updated:
Hira Pharmaceutical Industries Private Limited is a private limited company based in Miraj, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2020PTC337722. Its GSTIN is 27AAFCH2194A1ZV (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Akash Chandrakant Nandanikar and Akshay Ashok Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2421 Pratap Colony Block No. 3, Miraj, Maharashtra, India – 416410.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.45 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹18,470 (net margin -2.2%) and EBITDA of ₹56,307 (EBITDA margin 6.7%).
Company details
Recognitions & Rankings of Hira Pharmaceutical Industries
Contact details
Hira Pharmaceutical Industries Private Limited's registered office is in Miraj, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address2421 Pratap Colony Block No. 3, Miraj, Maharashtra, India – 416410
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Hira Pharmaceutical Industries Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hira Pharmaceutical Industries is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Hira Pharmaceutical Industries Private Limited, buy the company report.
Financials of Hira Pharmaceutical Industries Private Limited
FY 2025 filings availableHira Pharmaceutical Industries Private Limited reported revenue of ₹8.45 Lakh (up 228% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 228% in the latest year. EBITDA rose 207% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56,307 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹18,470 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | -2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hira Pharmaceutical Industries Private Limited, buy the company report.
Board of directors of Hira Pharmaceutical Industries Private Limited
Hira Pharmaceutical Industries has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akash Chandrakant Nandanikar | Director | 14 Feb 2020 | 6 Years 9 Months | Current |
| Akshay Ashok Patil | Director | 14 Feb 2020 | 6 Years 9 Months | Current |
Peer comparison
Hira Pharmaceutical Industries Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medsyn Therapeutics Private Limited | ₹9.04 Lakh (FY 2025) | 29.0% | Bangalore, Karnataka, India | |||
| Nutriliv Animal Health Care Private Limited | ₹8.88 Lakh (FY 2025) | -24.0% | Maval, Maharashtra, India | |||
| Airzen Projects Private Limited | ₹8.86 Lakh (FY 2025) | Vasai, Maharashtra, India | ||||
| Medicea Pharmaceutical Private Limited | ₹8.71 Lakh (FY 2025) | 14946.0% | Rajpura, Punjab, India | |||
| Sankor Health Care Private Limited | ₹8.54 Lakh (FY 2025) | 389.0% | Bangalore, Karnataka, India | |||
| Hira Pharmaceutical Industries Private Limitedthis company | ₹8.45 Lakh (FY 2024) | -₹18,470 | -2.2% | 228.0% | Miraj, Maharashtra, India | |
| Imedix Healthcare Private Limited | ₹8.38 Lakh (FY 2025) | -89.0% | Kolkata, West Bengal, India | |||
| Letos Lifesciences Private Limited | ₹8.28 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Equvila Healthcare Private Limited | ₹8.26 Lakh (FY 2024) | -47.0% | Panvel, Maharashtra, India | |||
| Human Bio-Logical Private Limited | ₹8.24 Lakh (FY 2025) | 10.0% | Thane, Maharashtra, India | |||
| Babari Agro Chemical Private Limited | ₹8.14 Lakh (FY 2024) | 159.0% | Bhavnagar, Gujarat, India |
To see the full peer comparison of Hira Pharmaceutical Industries Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hira Pharmaceutical Industries Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hira Pharmaceutical Industries Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hira Pharmaceutical Industries has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCH2194A1ZV | Maharashtra | Active | 13 Mar 2020 |
To see the full GST registrations and return filing status of Hira Pharmaceutical Industries Private Limited, buy the company report.
Recent activity
Hira Pharmaceutical Industries Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Akash Chandrakant Nandanikar was appointed as Director on 14 Feb 2020.
Frequently asked questions
Hira Pharmaceutical Industries is an active private limited company based in Miraj, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 February 2020 (6+ years old) and is registered under CIN U24299MH2020PTC337722.
Hira Pharmaceutical Industries has 2 current directors:
- Akash Chandrakant Nandanikar - Director
- Akshay Ashok Patil - Director
The latest financial statements of Hira Pharmaceutical Industries on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Hira Pharmaceutical Industries is 27AAFCH2194A1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Hira Pharmaceutical Industries is U24299MH2020PTC337722. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hira Pharmaceutical Industries was incorporated on 14 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Hira Pharmaceutical Industries by revenue are Medsyn Therapeutics Private Limited, Nutriliv Animal Health Care Private Limited, Airzen Projects Private Limited, Medicea Pharmaceutical Private Limited, Sankor Health Care Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Akash Chandrakant Nandanikar was appointed as Director on 14 Feb 2020. Akshay Ashok Patil was appointed as Director on 14 Feb 2020.
Yes, Hira Pharmaceutical Industries is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Hira Pharmaceutical Industries is at 2421 Pratap Colony Block No. 3, Miraj, Maharashtra, India – 416410.
Hira Pharmaceutical Industries operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

